Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
Clinical trial NCT01312311 · UNKNOWN
Trial details
- NCT number
- NCT01312311
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2011-05-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.